Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Biocytogen Pharmaceuticals Beijng Co Ltd have a median target of 14.97, with a high estimate of 16.36 and a low estimate of 13.58. The median estimate represents a 137.55% increase from the last price of 6.30.
High | 159.6% | 16.36 |
Med | 137.6% | 14.97 |
Low | 115.5% | 13.58 |
Earnings history & estimates in CNY
Average growth rate | +39.24% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +34.28% |
More ▼